#1966 Participation rate and yield of screening for albuminuria in the primary care setting for early identification of chronic kidney disease (SALINE)
Dominique van Mil(University Medical Center Groningen), Hiddo J.L. Heerspink(University Medical Center Groningen), Marika T. Leving(General Practitioners Research Institute), Nilouq Stoker(General Practitioners Research Institute), Janwillem Kocks(University Medical Center Groningen), Martine Oudenhuijzen(AstraZeneca (Netherlands)), Ronald Gansevoort(University Medical Center Groningen), Lyanne M. Kieneker(University Medical Center Groningen), Evelien Harms(General Practitioners Research Institute), Iris van Geer-Postmus(General Practitioners Research Institute)
Cited by 1
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
|The Lancet|2012|1.4k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990